BioSpace News Archive

The National University of Science and Technology MISiS Scientists Synthesize Nanoparticle-Antioxidants to Treat Strokes and Spinal Cord Injuries

An international science team has developed an innovative therapeutic complex based on multi-layer polymer nano-structures of superoxide dismutase.

January 23, 2018
·
3 min read
FDA

TECHLAB Snags FDA Nod to Market CAMPYLOBACTER QUIK CHEK and CAMPYLOBACTER CHEK Tests

Both tests are intended to aid diagnosis of campylobacteriosis.

January 23, 2018
·
2 min read
Business

ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration With Janssen

ChemDiv announced at the 36th Annual J.P. Morgan Healthcare Conference the expansion of its hit identification collaboration with Janssen R&D and extending it into finding potent anti-infective drug candidates.

January 23, 2018
·
2 min read
Nemaura Medical Inc. Announces Uplisting to NASDAQ Capital Market on January 25, 2018

Nemaura Medical Inc. today announced that its shares of common stock were approved for listing on the NASDAQ Capital Market.

January 23, 2018
·
3 min read
Business

Akari Therapeutics Strengthens Board With Two Senior Industry Appointments

The company appointed Michael Grissinger and Dr. Peter Feldschreiber to the Company’s Board of Directors with immediate effect.

January 23, 2018
·
6 min read
BioMidwest

KemPharm Receives Patent Grant for KP606, a Prodrug of Oxycodone

KemPharm was recently issued USPTO for its patent application related to KP606 entitled “Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof.”

January 23, 2018
·
4 min read
Pharm Country

Tonix Pharmaceuticals Receives Notice of Allowance for New U.S. Patent for the Active Ingredient in Tonmya (Cyclobenzaprine HCl Sublingual Tablets)

Tonix is in Phase 3 development of Tonmya, a FDA-designated Breakthrough Therapy for the treatment of PTSD.

January 23, 2018
·
6 min read
Rexgenero Secures Innovate UK Grant

The grant is a consortium between the Cell and Gene Therapy Catapult, TrakCel and Fisher Bioservices.

January 23, 2018
·
2 min read
Pharm Country

Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events

Patients are being scheduled for final study visits commencing March 1, 2018. Amarin maintains its guidance to report top-line results from the study before the end of Q3 2018.

January 23, 2018
·
9 min read
Deals

Orion to Investigate Possible Sale of Orion Diagnostica

A possible result of the investigation may also be that Orion Diagnostica will continue as a part of the Orion Group.

January 23, 2018
·
1 min read